SCTB39G
/ Sinocelltech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 25, 2025
Phase I/II Study of SCTB39G in Advanced Solid Tumours
(clinicaltrials.gov)
- P1/2 | N=30 | Not yet recruiting | Sponsor: Sinocelltech Ltd.
New P1/2 trial • Solid Tumor
1 to 1
Of
1
Go to page
1